Are European investors risking an overdose?

There were no shortage of takers for the debt financing backing the buyout of German drugs firm Stada, despite concerns over the structure.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this